Márcio Vinícius Fagundes Donadio Selected Research

Márcio Vinícius Fagundes Donadio Research Topics

Disease

7	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2019
5	Neoplasms (Cancer) 02/2022 - 02/2011
5	Asthma (Bronchial Asthma) 01/2022 - 10/2016
5	Necrosis 10/2020 - 02/2011
4	Inflammation (Inflammations) 11/2021 - 11/2015
3	Fibrosis (Cirrhosis) 11/2021 - 10/2018
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2021 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 12/2016
2	Acute Lung Injury 01/2020 - 06/2011
2	Body Weight (Weight, Body) 10/2018 - 06/2011
2	AIDS-Related Complex (ARC) 04/2006 - 04/2004
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2021
1	Liver Diseases (Liver Disease) 11/2021
1	Respiratory Sounds (Crackle) 11/2021
1	Cough 11/2021
1	Bronchiolitis 11/2021
1	Viral Bronchiolitis 03/2021
1	Lung Injury 01/2021
1	Sleep Wake Disorders 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2019
1	Myocardial Infarction 08/2019
1	Coronary Disease (Coronary Heart Disease) 08/2019
1	Insulin Resistance 11/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2018
1	Pseudomonas Infections 11/2015
1	Sepsis (Septicemia) 12/2011
1	Pleurisy (Pleuritis) 06/2011
1	Lordosis 05/2006

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 11/2015
2	Gallic AcidIBA 02/2022 - 12/2016
2	AntioxidantsIBA 02/2022 - 12/2016
2	octyl gallateIBA 02/2022 - 01/2020
2	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2021 - 01/2021
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 11/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 10/2020
2	CollagenIBA 01/2021 - 10/2018
2	CPBMF65IBA 01/2021 - 12/2020
2	Interleukin-10 (Interleukin 10)IBA 08/2019 - 12/2016
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2019
2	Angiotensin IIIBA 11/2015 - 04/2004
2	Progesterone FDA LinkGeneric 05/2006 - 04/2006
2	ProlactinIBA 04/2006 - 04/2004
1	methoxyeugenolIBA 11/2021
1	NF-kappa B (NF-kB)IBA 11/2021
1	Messenger RNA (mRNA)IBA 11/2021
1	Propolis (Bee Bread)IBA 11/2021
1	Bronchodilator Agents (Bronchodilators)IBA 11/2021
1	indium-bleomycinIBA 01/2021
1	UridineIBA 01/2021
1	Uridine PhosphorylaseIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Food Additives (Food Additive)IBA 01/2020
1	Sterol Regulatory Element Binding Protein 1IBA 01/2020
1	InterleukinsIBA 08/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019
1	Liraglutide FDA Link 01/2019
1	Clostridium perfringens epsilon-toxinIBA 01/2019
1	CholesterolIBA 11/2018
1	Glucose (Dextrose)FDA LinkGeneric 11/2018
1	Triglycerides (Triacylglycerol)IBA 11/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2018
1	Interleukin-8 (Interleukin 8)IBA 12/2016
1	phenolic acidIBA 12/2016
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 12/2016
1	Trypan Blue FDA Link 12/2016
1	Antineoplastic Agents (Antineoplastics)IBA 12/2016
1	Interleukin-12 (IL 12)IBA 12/2016
1	OvalbuminIBA 10/2016
1	Acetylcysteine (Siran)FDA LinkGeneric 12/2011
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2011
1	LipopolysaccharidesIBA 06/2011
1	CarrageenanIBA 06/2011
1	Dizocilpine Maleate (Dizocilpine)IBA 06/2011
1	Cytotoxins (Cytolysins)IBA 02/2011
1	Cisplatin (Platino)FDA LinkGeneric 02/2011
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2006
1	Peptides (Polypeptides)IBA 04/2004
1	Losartan (Cozaar)FDA LinkGeneric 04/2004
1	Ether (Diethyl Ether)IBA 04/2004

Therapy/Procedure

6	Therapeutics 01/2022 - 10/2018
2	Resistance Training 01/2022 - 01/2021
1	Traditional Medicine (Folk Remedies) 11/2021
1	Aftercare (After-Treatment) 11/2021
1	Noninvasive Ventilation 04/2021
1	Continuous Positive Airway Pressure 04/2021
1	Chest Wall Oscillation 03/2021
1	Respiratory Therapy (Therapy, Respiratory) 11/2020
1	Physical Therapy Modalities (Physical Therapy Technique) 11/2020
1	Stents 08/2019
1	Cannula 04/2004